Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov ID: NCT04130919

Public ClinicalTrials.gov record NCT04130919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Blinded, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of GS-4875 in Subjects With Moderately to Severely Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to demonstrate the efficacy of tilpisertib (formerly GS-4875) compared with placebo control in achieving clinical remission per modified Mayo Clinic Score (MCS) in adults with moderately to severely active ulcerative colitis (UC).

Study identification

NCT ID
NCT04130919
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
19 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 19, 2019
Primary completion
Feb 24, 2021
Completion
Dec 13, 2021
Last update posted
Aug 23, 2022

2019 – 2021

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
23
Facility City State ZIP Site status
Gut P.C., dba Digestive Health Specialists of the Southeast Dothan Alabama 36305
Om Research LLC Lancaster California 93534
United Medical Doctors Murrieta California 92563
Alliance Clinical Research Poway California 92064
Alliance Medical Research Coral Springs Florida 33071
Encore Borland-Groover Clinical Research Jacksonville Florida 32256
A Plus Research, Inc Miami Florida 33144
BRCR Medical Center Inc. Plantation Florida 33322
Advanced Medical Research Center Port Orange Florida 32127
Gastrointestinal Specialists of Georgia Marietta Georgia 30060
Atlanta Gastroenterology Specialists, PC Suwanee Georgia 30024
Louisiana Research Center, LLC Shreveport Louisiana 71105
Kansas City Research Institute Kansas City Missouri 64131
Advanced Biomedical Research of America Las Vegas Nevada 89123
Consultants for Clinical Research Cincinnati Ohio 45219
Gastroenterology Associates of Orangeburg Orangeburg South Carolina 29118
Vanderbilt University Medical Center - IBD Clinic Nashville Tennessee 37212-1375
Allied Digestive Disease Center Cypress Texas 77429
Southwest Clinical Trials Houston Texas 77074
Clinical Associates in Research Therapeutics of America, LLC San Antonio Texas 78212
Texas Digestive Disease Consultants San Marcos Texas 78666
Texas Digestive Disease Consultants Southlake Texas 76092
Allegiance Research Specialists, LLC Wauwatosa Wisconsin 53225

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04130919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2022 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04130919 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →